Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

The Quest for Improving Sickle Cell Care: Creating High-Level Quality Improvement Goals with a Care Process Team

Titilope Fasipe, Anne Dykes, Devin Olivares-Reed, Truc Baccam, Krystle Bartley, Trinh T. Nguyen, Elise Blair, Barkha Chandwani, Sandra Knight, Rhoda Phillips, Alaundra Carmouche, Kalindi Yajnik Narine, Jennifer Tran, Kathleen Magee, Lisa Bomgaars, Binita Patel, Rona Sonabend, Venee Tubman

Blood (2023) 142 (Supplement 1): 3682.

https://doi.org/10.1182/blood-2023-191064

Published: 2023

Journal Articles

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Jacqueline Halton, MD, Leonardo R. Brandao, MD, Matteo Luciani, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Ildar Nurmeev, MD, Anjali Sharathkumar, MD, Pavel Svirin, MD, Kirill Gorbatikov, MD, Igor Tartakovsky, MD, Monika Simetzberger, DI, Fenglei Huang, PhD, Zhichao Sun, PhD, Jörg Kreuzer, MD, Savion Gropper, MD, Martina Brueckmann, MD, Manuela Albisetti, MD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-136682

Published: 2020

Journal Articles

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Leonardo R. Brandao, MD, Igor Tartakovsky, MD, Manuela Albisetti, MD, Lisa Bomgaars, MD, Elizabeth Chalmers, MD, Lesley Mitchell, MD, Matteo Luciani, MD, Paola Saracco, MD, Judy Felgenhauer, MD, Olga Lvova, MD, Monika Simetzberger, DI, Zhichao Sun, PhD, Ingrid Gergei, MD, Martina Brueckmann, MD, Jacqueline Halton, MD

Blood (2020) 136 (Supplement 1): 35–36.

https://doi.org/10.1182/blood-2020-136695

Published: 2020

Journal Articles

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

Leonardo R. Brandão, Manuela Albisetti, Jacqueline Halton, Lisa Bomgaars, Elizabeth Chalmers, Lesley G. Mitchell, Ildar Nurmeev, Pavel Svirin, Tomas Kuhn, Ondrej Zapletal, Igor Tartakovsky, Monika Simetzberger, Fenglei Huang, Zhichao Sun, Jörg Kreuzer, Savion Gropper, Martina Brueckmann, Matteo Luciani

Blood (2020) 135 (7): 491–504.

https://doi.org/10.1182/blood.2019000998

Published: 2020

Includes: Supplemental data

Journal Articles

Treatment of Patients with Severe Congenital Protein C Deficiency in a Registry Study of Protein C Concentrate (Human)

Marilyn Manco-Johnson, MD, Hans-Joerg Hertfelder, MD PhD, Theodosia A. Kalfa, MD PhD, Emmett H. Broxson, Jr., MD, Lisa Bomgaars, MD, Amy D. Shapiro, MD, Dyck-Jones Jacqueline, PhD, Sandra Ehrle, MD, Maureen Finnerty, David Gelmont, MD, Leman Yel, MD, Mahmoud Loghman-Adham, MD

Blood (2016) 128 (22): 2605.

https://doi.org/10.1182/blood.V128.22.2605.2605

Published: 2016

Journal Articles

Prothrombotic Markers As Predictors of Thrombosis in Newly Diagnosed Cancer Patients

Ozlem Bilen, MD, Maha AAA Abd Elbasset, MD, Jacquelyn Michele LaGrone, MD, Imelda Tija, MD, Lisa Bomgaars, MD, Jun Teruya, MD, DSc

Blood (2011) 118 (21): 2298.

https://doi.org/10.1182/blood.V118.21.2298.2298

Published: 2011

Journal Articles

A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim in Children with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP).

George R. Buchanan, MD, Lisa Bomgaars, MD, James B. Bussel, MD, Diane J. Nugent, MD, David J. Gnarra, MD, Victor S Blanchette, FRCP, Kun Nie, Melissa Eisen, MD, Dietmar Berger, MD, PhD

Blood (2009) 114 (22): 680.

https://doi.org/10.1182/blood.V114.22.680.680

Published: 2009

Journal Articles

Use of Pharmacogenetic Factors to Predict Warfarin Dose in Children - a Retrospective Cohort Study

Emma Jones, MD, Mary Bauman, RN, BA, M. Patricia Massicotte, MD, Brian Gage, MD, Ebony Courtney, MA, Lisa Bomgaars, MD

Blood (2008) 112 (11): 988.

https://doi.org/10.1182/blood.V112.11.988.988

Published: 2008

Journal Articles

“Aspirin Resistance”: Low Prevalence and Assay Discordance in a Pediatric Cohort.

Donald L. Yee, MD, Bogdan Dinu, MD, Jun Teruya, MD, DSc, Paul F. Bray, MD, Lisa Bomgaars, MD

Blood (2006) 108 (11): 886.

https://doi.org/10.1182/blood.V108.11.886.886

Published: 2006

Journal Articles

Pharmacokinetics of Vincristine in Infants with Acute Lymphoblastic Leukemia.

Lisa Bomgaars, MD, Chelsea Hunter, Rong Huang, Mark Schmidt, Ph.D., ZoAnn Dreyer, MD, Susan Blaney, MD, Stacey Berg, MD, D.J. Murry, PharmD

Blood (2004) 104 (11): 4502.

https://doi.org/10.1182/blood.V104.11.4502.4502

Published: 2004

NARROW

The Quest for Improving Sickle Cell Care: Creating High-Level Quality Improvement Goals with a Care Process Team

Dabigatran Etexilate in Children with Venous Thromboembolism: Results of the Open-Label, Phase IIb/III, Randomized Diversity Clinical Trial

Efficacy and Safety of Dabigatran in the Treatment and Secondary Prophylaxis of Children with Venous Thromboembolism and Thrombophilia

Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children

Treatment of Patients with Severe Congenital Protein C Deficiency in a Registry Study of Protein C Concentrate (Human)

Prothrombotic Markers As Predictors of Thrombosis in Newly Diagnosed Cancer Patients

A Randomized, Double-Blind, Placebo-Controlled Phase 1/2 Study to Determine the Safety and Efficacy of Romiplostim in Children with Chronic Immune (Idiopathic) Thrombocytopenic Purpura (ITP).

Use of Pharmacogenetic Factors to Predict Warfarin Dose in Children - a Retrospective Cohort Study

“Aspirin Resistance”: Low Prevalence and Assay Discordance in a Pediatric Cohort.

Pharmacokinetics of Vincristine in Infants with Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only